Display Settings:

Format

Send to:

Choose Destination
    Neurology. 2001 May 8;56(9):1227-9.

    Guillain-Barré syndrome associated with IgG monospecific to ganglioside GD1b.

    Source

    Department of Neurology, National Shimosizu Hospital, Chiba, Japan.

    Abstract

    The authors examined serum antiglycolipid antibodies in 445 patients with Guillain-Barré syndrome (GBS). Among them, nine had anti-GD1b IgG antibodies with no reactivity to other glycolipids tested. All those patients had sensory disturbance, and none had the primary axonal form. Anti-GD1b IgG antibodies may bind to primary sensory neurons and paranodal myelin, where GD1b is localized, and be involved in the pathogenesis of sensory disturbance and demyelination. However, more study is needed to substantiate the roles of anti-GD1b IgG antibodies.

    PMID:
    11342695
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for HighWire Press

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk